|
|
Browse products Anticancer agents in preclinical trials Anticancer molecular libraries Other drug agents
|
MedKoo product information: PF-337210
PF337210 is a potent, selective small molecule inhibitor of VEGFRs. A solution formulation was developed for PF337210 intended for the treatment of age-related macular degeneration..
Current developer: Pfizer Global Research & Development,
|
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
||||||||||||||
About us | Services | Products | News | Careers | Contact us